BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31823290)

  • 1. High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
    Zaanan A; Calmel C; Henriques J; Svrcek M; Blons H; Desbois-Mouthon C; Merabtene F; Goumard C; Parc Y; Gayet B; Taieb J; Validire P; Louvet C; Fléjou JF; Le Bouc Y; Praz F
    Cell Oncol (Dordr); 2020 Apr; 43(2):237-247. PubMed ID: 31823290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
    Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
    J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.
    Ludovini V; Flacco A; Bianconi F; Ragusa M; Vannucci J; Bellezza G; Chiari R; Minotti V; Pistola L; Tofanetti FR; Siggillino A; Baldelli E; Sidoni A; Daddi N; Puma F; Varella-Garcia M; Crinò L
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):671-80. PubMed ID: 23314677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
    Mountzios G; Kostopoulos I; Kotoula V; Sfakianaki I; Fountzilas E; Markou K; Karasmanis I; Leva S; Angouridakis N; Vlachtsis K; Nikolaou A; Konstantinidis I; Fountzilas G
    PLoS One; 2013; 8(1):e54048. PubMed ID: 23365645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
    Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
    Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer.
    Han L; Zhang GF; Cheng YH; Zhao QC
    Jpn J Clin Oncol; 2016 Dec; 46(12):1127-1134. PubMed ID: 27737962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Role of Mismatch Repair Status and CDX-2 Expression with Inflammatory Markers and Pathological Risk Factors in Stage II and III Colon Cancer: Multicenter Real-Life Data.
    Aydin SG; Olmez OF; Selvi O; Geredeli C; Ozden F; Bilici A; Acikgoz O; Karci E; Kutlu Y; Hamdard J; Aydin A
    J Gastrointest Cancer; 2024 Mar; 55(1):227-236. PubMed ID: 37347353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer.
    Sfakianaki M; Papadaki C; Tzardi M; Trypaki M; Alam S; Lagoudaki ED; Messaritakis I; Zoras O; Mavroudis D; Georgoulias V; Souglakos J
    Cancer Res Treat; 2019 Oct; 51(4):1518-1526. PubMed ID: 30913862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
    Chong KY; Subramanian A; Mokbel K; Sharma AK
    J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.
    Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma.
    Kikuchi R; Sonobe M; Kobayashi M; Ishikawa M; Kitamura J; Nakayama E; Menju T; Miyahara R; Huang CL; Date H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S412-20. PubMed ID: 21732141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancer.
    Reinmuth N; Kloos S; Warth A; Risch A; Muley T; Hoffmann H; Thomas M; Meister M
    Hum Pathol; 2014 Jun; 45(6):1162-8. PubMed ID: 24745618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.
    Fu P; Ibusuki M; Yamamoto Y; Hayashi M; Murakami K; Zheng S; Iwase H
    Breast Cancer Res Treat; 2011 Nov; 130(1):307-17. PubMed ID: 21748295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
    Kalla Singh S; Tan QW; Brito C; De León M; De León D
    Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.